PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7257826-4	1981	The uptake was moderately potentiated by the MAO inhibitor iproniazid (3 micrometers) after 30-60 min.	Iproniazid	59-69	monoamine oxidase A	Rattus norvegicus	45-48	
3664088-8	1987	In vitro treatment with the monoamine oxidase (MAO) inhibitors, iproniazid or pargyline, did not potentiate responses to either noradrenaline or isoprenaline.	Iproniazid	64-74	monoamine oxidase A	Rattus norvegicus	28-45	
3664088-8	1987	In vitro treatment with the monoamine oxidase (MAO) inhibitors, iproniazid or pargyline, did not potentiate responses to either noradrenaline or isoprenaline.	Iproniazid	64-74	monoamine oxidase A	Rattus norvegicus	47-50	
7456355-3	1980	The MAO activating effect of N-methyl octahydronaphthazepines in the brain homogenates occurred when the enzymatic activity was previously inhibited with iproniazid.	Iproniazid	154-164	monoamine oxidase A	Rattus norvegicus	4-7	
6772465-1	1980	In rat, histamine metabolism is altered by some nonspecific inhibitors of monoamine oxidase (MAO) such as iproniazid, and, to a lesser extent, tranylcypromine.	Iproniazid	106-116	monoamine oxidase A	Rattus norvegicus	74-91	
6772465-1	1980	In rat, histamine metabolism is altered by some nonspecific inhibitors of monoamine oxidase (MAO) such as iproniazid, and, to a lesser extent, tranylcypromine.	Iproniazid	106-116	monoamine oxidase A	Rattus norvegicus	93-96	
44325-3	1979	alpha-blockers (phenoxybenzamine and phentolamine) and monoamine oxidase (MAO) inhibitor (iproniazide) produced an increased accumulation of 5-HT fluorescence in the apical regions of acinar cells where the zymogen granules are stored.	Iproniazid	90-101	monoamine oxidase A	Rattus norvegicus	55-72	
44325-3	1979	alpha-blockers (phenoxybenzamine and phentolamine) and monoamine oxidase (MAO) inhibitor (iproniazide) produced an increased accumulation of 5-HT fluorescence in the apical regions of acinar cells where the zymogen granules are stored.	Iproniazid	90-101	monoamine oxidase A	Rattus norvegicus	74-77	
499103-1	1979	Rat thyroid monoamine oxidase (MAO) was inhibited by the non-hydrazine derivatives paragyline and tranylcypromine to a higher degree than the hydrazine derivative iproniazide.	Iproniazid	163-174	monoamine oxidase A	Rattus norvegicus	31-34	
108709-1	1979	Pretreatment with the MAO-inhibitors iproniazid, clorgyline, or deprenyl abolishes the effects of LSD on the conditioned avoidance response (CAR) in rats.	Iproniazid	37-47	monoamine oxidase A	Rattus norvegicus	22-25	
837973-8	1977	The data indicate that chronic glucocorticoid treatment may have a slight inhibitory effect on brain MAO and also has the ability to partially reverse or antagonize the inhibition of MAO caused by iproniazid.	Iproniazid	197-207	monoamine oxidase A	Rattus norvegicus	183-186	
837973-2	1977	Opposite results with dexamethasone were obtained in iproniazid (MAO-inhibited)-treated rats.	Iproniazid	53-63	monoamine oxidase A	Rattus norvegicus	65-68	
12389-8	1976	The pI curves for inhibition of MAO activity by harmine, pargyline and iproniazid were similar and almost the same pI 50 values for the respective inhibitors were obtained with the two substrates.	Iproniazid	71-81	monoamine oxidase A	Rattus norvegicus	32-35	
10799660-5	2000	These potencies were similar to those of the antidepressant MAO inhibitors iproniazid and moclobemide.	Iproniazid	75-85	monoamine oxidase A	Rattus norvegicus	60-63	
1143390-0	1975	Proceedings: Age dependent recovery of rat brain MAO activity after administration of a single dose of iproniazid and pargyline.	Iproniazid	103-113	monoamine oxidase A	Rattus norvegicus	49-52	
16955968-3	1965	The MAO-inhibitors phenylcyclopropylamino hydrochloride and nialamide show enhancement of activity in most combinations whereas iproniazid never does.	Iproniazid	128-138	monoamine oxidase A	Rattus norvegicus	4-7	
7901387-1	1993	Time- and dose-response analyses were undertaken to investigate the effects of the substituted hydrazine monoamine oxidase (MAO) inhibitors iproniazid and nialamide on the following: MAO-A and -B activity; levels of gamma-aminobutyric acid (GABA), alanine (ALA), and the neurotransmitter amines dopamine, noradrenaline, and 5-hydroxytryptamine (serotonin) and their acid metabolites; and the activity of GABA-transaminase and ALA-transaminase.	Iproniazid	140-150	monoamine oxidase A	Rattus norvegicus	124-127